The industry is anticipated to experience significant expansion over the projected period as a result of rising research activities for the discovery of new medications for the global endometriosis treatment market. The introduction of new products by manufacturers is also anticipated to fuel market expansion for endometriosis treatments worldwide. Other variables, including an increase in endometriosis prevalence, a strong pipeline, and increased awareness of endometriosis, are anticipated to promote the market expansion for Endometriosis Treatments. Intrauterine Systems (IUS), among other alternative treatment alternatives, are a major driver of the market's resumption of growth. IUS is a T-shaped device inserted in womb by the doctor. Endometriosis therapy also includes the use of oral contraceptives or GnRH agonists. Most of these treatments have negative effects on the body owing to hormonal shifts, and they also increase the likelihood of endometriosis recurrence.
Key Competitors in the Endometriosis Treatment Industry:
1. Astra Zeneca Plc.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. In June 2020, AstraZeneca announced its collaboration with Accent Therapeutics to discover, develop, and commercialize transformative therapeutics targeting RNA-modifying proteins for the treatment of cancer.
2. Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
3. Astellas Pharma Inc
Astellas Pharma is a pharmaceutical company conducting business in more than 70 countries around the world. Founded in April, 2005, headquartered in Tokyo, Japan . In February 2020, Astellas Pharma Inc. and Seattle Genetics Inc. announced that the U.S. FDA has granted Breakthrough Therapy designation for PADCEV, in combination with immune therapy pembrolizumab in First-line advanced bladder cancer.
4. Bayer AG
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. In 2018, LASCO distributors in association with Bayer healthcare launched new drug visanne, which is indicated for endometriosis treatment.
5. Meditrina Pharmaceuticals
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.the company was founded in 2006, headquartered in Michigan, U.S.
6. Abbvie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. In 2017, AbbVie, Biopharmaceutical Company in co-operation with Neurocrine Biosciences Inc submitted New Drug Application (NDA) to the U.S. Food and drug Administration (FDA) for a new drug named elagolix. It is an orally administering gonadotropin releasing hormone antagonist, which is being evaluated for management of pain associated with endometriosis.
7. PfizerInc
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide. In December, 2022 announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan
8. Takeda Pharmaceutica
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
9. Neurocrine Biosciences Inc
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids* , as well as clinical programs in multiple therapeutic areas. The company was founded in 1992, headquartered in San Diego, California.
*Definition- The endometrium, the tissue that lines the inside of the uterus, develops outside the uterus in endometriosis, a painful medical condition.
